DSP Sales Down 0.8% Due to Long-Listed Product Sales Decline, Double-Digit Growth in Profits

Dainippon Sumitomo Pharma’s (DSP) sales inched down 0.8% from a year earlier to 347,724 million yen in the fiscal year ended March 2013, according to a financial report released by the company on May 9. Although DSP’s North America and...read more